跳至主要内容
临床试验/NCT04379219
NCT04379219Unknown4 期

Surgery Alone Versus Methotrexate Before Surgery in Cases of First Trimester Cesarean Scar Pregnancy: a Randomized Controlled Trial

Mansoura University1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2019年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
56
试验地点
1
主要终点
Estimated blood loss intraoperative

研究概览

简要总结

There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez & Tulandi, 2017). A variety of medical and surgical treatment modalities for CSP have been reported; however, most of these are based on low-level evidence(Sun et al., 2019).

详细描述

This will be a randomized clinical trial to evaluate the effect of administration of methotrexate before surgery in reducing bleeding, injury to bladder and ureter, operative time and removing of CSP mass.This will be in comparison to surgery alone in cases of first trimester cesarean scar pregnancy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Gestational age before 13 w
  • Past history of 1 or more CS
  • Presence of GS implanted on cesareans scar

排除标准

  • Presence of severe vaginal bleeding (emergency)
  • Previous history of uterine surgery other than CS
  • The whole mass is interior and the bulge is more in the cavity
  • Bleeding disorder
  • Patient not candidate for methotrexate (Positive fetal heart pulsation,
  • Patient refuse to participate in the study

研究组 & 干预措施

surgery

Active Comparator
  • Valid consent
  • Anathesia , (regional may br converted into general ). IV antibiotic ( cefotaxime 1 gm I.V )
  • Laparotomy transverse incision (pfannenstiel incision)
  • Exploration of the abdominal cavity
  • Identification of the uterus, dissection of the bladder, incision of the uterus and excision of the CSP mass.
  • Surgical repair of the uterine incision, and the abdomen

干预措施: Methotrexate (Drug)

methotrexate before surgery

Active Comparator

Valid consent

  • patient will receive 50 mgm /m2 of methtrexate after full investigation ( CBC, serum creatinie, AlT, AST), 1 week before surgery.
  • Anathesia , (regional may br converted into general ). IV antibiotic ( cefotaxime 1 gm I.V )
  • Laparotomy transverse incision (pfannenstiel incision)
  • Exploration of the abdominal cavity
  • Identification of the uterus, dissection of the bladder, incision of the uterus and excision of the CSP mass.
  • Surgical repair of the uterine incision, and the abdomen

干预措施: Methotrexate (Drug)

结局指标

主要结局

Estimated blood loss intraoperative

时间窗: intraoperative blood loss

the amount of blood in soaked towels and vacuum aspiration

次要结局

  • need further management(1 month)
  • • Rate of urological injury(immediatly and 1 week post operative)
  • • Rate of readmission, relaparotomy(with in 1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maher elesawi kamel elesawi

Lecturer of obstetric and gynecology

Mansoura University

研究点 (1)

Loading locations...

相似试验

Surgery Alone Versus Methotrexate Before Surgery in... | 临床试验